title: Metastatic colorectal cancer: irinotecan plus infusional, bolus or oral fluoropyrimidines as first-line treatment.
authors.affiliation: Department of Clinical Pharmacology, University of Oxford, Oxford, UK. david.kerr@clinicalpharmacology.oxford.ac.uk
authors.forename: David J
authors.initials: DJ
authors.lastname: Kerr